Grafa News and Videos — Page 835

Edible Garden (NASDAQ:EDBL) reported strong top-line revenue growth for the first quarter of 2026, driven by retail expansion and broader consumer adoption of its product portfolio, even as heavy capital deployment for its beverage infrastructure weighed on near-term profitability.

Arrive AI (NASDAQ:ARAI), a company developing AI-powered autonomous vehicle and robotics solutions, announced its first-quarter 2026 financial results and provided an operational update.

RenX Enterprises (NASDAQ:RENX) reported strong sequential revenue expansion for the first quarter of 2026, driven by higher utilization across its contracted hauling agreements and accelerating bulk material sales, even as advanced technology integration costs left consolidated bottom-line metrics in a deficit.

Creative Realities (NASDAQ:CREX) reported a significant increase in top-line revenue for the first quarter of fiscal 2026, driven primarily by the financial integration of its Cineplex Digital Media acquisition, even as margin compression and one-time structural charges pulled bottom-line metrics into a deficit.

Polish lawmakers have approved a long-debated cryptocurrency bill as the country moves closer to the European Union’s Markets in Crypto-Assets regulation.

Palvella Therapeutics (NASDAQ:PVLA) reported positive clinical data from its Phase 2 TOIVA trial evaluating its proprietary topical formulation of rapamycin, detailing significant therapeutic benefits for patients suffering from rare vascular skin disorders.

Thorchain has suffered an estimated $10 million to $11 million exploit after attackers manipulated its vault churn process across several major blockchains.

RBC Bearings Incorporated (NYSE:RBC) reported strong financial results for the fourth quarter of fiscal 2026, beating Wall Street expectations as accelerating production rates across commercial aviation and defense programs catalyzed top-line growth.

Coinbase has marked its 14th anniversary with chief executive Brian Armstrong setting out an ambitious target to bring 1 billion people into the open financial system.

MiNK Therapeutics (NASDAQ:INKT) reported its first-quarter 2026 financial results and operational milestones, highlighting clinical advancement within its invariant natural killer T (iNKT) cell platform alongside successful balance sheet deleveraging.